Fibroblast growth factor receptor substrate 2 (FRS2) exhibits high positivity rates in primary RPLS tumor specimens, demonstrating significant correlation with recurrence dynamics and survival outcomes (Chen and Miao, 2023). The gene discussed is FRS2; the disease is neoplasm.